Corrigendum to "Comparative Varicella vaccine effectiveness during outbreaks in day care centers" [Vaccine 28 (2010) 686-691] (DOI:10.1016/j.vaccine.2009.10.086);Comparative varicella vaccine effectiveness during outbreaks in day-care centres

Vaccine

Volumn 28, Issue 3, 2010, Pages 686-691

  Spackova, M ^a,b   Wiese Posselt, M ^b   Dehnert, M ^b   Matysiak Klose, D ^b   Heininger, U ^c   Siedler, A ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Breakthrough varicella; Outbreak investigation; Vaccination coverage; Vaccine effectiveness; Varicella

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; PRIORIX TETRA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; DAY CARE; DISEASE SEVERITY; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; VACCINATION;

EID: 71249083026     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.017     Document Type: Erratum

References (35)

1. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 10 3 (1996) 571-581
2. Heyman DL. Control of Communicable Diseases Manual, 18th ed. 204. American Public Health Association, Ref Type: Generic.
3. Heininger U., and Seward J.F. Varicella. Lancet 368 9544 (2006) 1365-1376
4. Takahashi M., Otsuka T., Okuno Y., Asano Y., and Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2 7892 (1974) 1288-1290
5. Sadzot-Delvaux C., Rentier B., Wutzler P., Asano Y., Suga S., Yoshikawa T., et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis 197 Suppl. 2 (2008) S185-S190
6. Plotkin S.A. MWAOMaPAOM. Vaccine. 5th ed. (2009)
7. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand. Epidemiologisches Bull 30 July (2004) 235-250 [Ref Type: Generic]
8. Orenstein W.A., Bernier R.H., and Hinman A.R. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 10 (1988) 212-241
9. Chen R.T., and Orenstein W.A. Epidemiologic methods in immunization programs. Epidemiol Rev 18 2 (1996) 99-117
10. Seward J.F., Marin M., and Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis 197 Suppl. 2 (2008) S82-S89
11. Miron D., Lavi I., Kitov R., and Hendler A. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 24 3 (2005) 233-236
12. Passwell J.H., Hemo B., Levi Y., Ramon R., Friedman N., and Lerner-Geva L. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr Infect Dis J 23 3 (2004) 221-226
13. Sheffer R., Segal D., Rahamani S., Dalal I., Linhart Y., Stein M., et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 24 5 (2005) 434-437
14. Arnedo-Pena A., Puig-Barbera J., znar-Orenga M.A., Ballester-Albiol M., Pardo-Serrano F., Bellido-Blasco J.B., et al. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain. Pediatr Infect Dis J 25 9 (2006) 774-778
15. Kilic A., Unuvar E., Yilmaz C., Yildiz I., Oguz F., and Sidal M. The effectiveness of varicella vaccination during an outbreak in a children's day-care center. Vaccine 26 27-28 (2008) 3371-3372
16. Bayer O., Heininger U., Heiligensetzer C., and von K.R. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine 25 37-38 (2007) 6655-6660
17. Robert Koch-Institut. Begründung der STIKO für eine allgemeine Varizellenimpfung. Epidemiologisches Bull 49 (2004) 421-423 [Ref Type: Generic]
18. Tugwell B.D., Lee L.E., Gillette H., Lorber E.M., Hedberg K., and Cieslak P.R. Chickenpox outbreak in a highly vaccinated school population. Pediatrics 113 3 Pt 1 (2004) 455-459
19. Lopez A.S., Guris D., Zimmerman L., Gladden L., Moore T., Haselow D.T., et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?. Pediatrics 117 6 (2006) e1070-e1077
20. Kuter B., and Schodel F. Second varicella vaccine dose. Pediatr Infect Dis J 26 2 (2007) 193-194
21. Arvin A., and Gershon A. Control of varicella: why is a two-dose schedule necessary?. Pediatr Infect Dis J 25 6 (2006) 475-476
22. Kuter B., Matthews H., Shinefield H., Black S., Dennehy P., Watson B., et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23 2 (2004) 132-137
23. Watson B. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. J Infect Dis 197 Suppl. 2 (2008) S143-S146
24. Marin M., Guris D., Chaves S.S., Schmid S., and Seward J.F. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56 RR-4 (2007) 1-40
25. Chaves S.S., Gargiullo P., Zhang J.X., Civen R., Guris D., Mascola L., et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 356 11 (2007) 1121-1129
26. Dworkin M.S., Jennings C.E., Roth-Thomas J., Lang J.E., Stukenberg C., and Lumpkin J.R. An outbreak of varicella among children attending preschool and elementary school in Illinois. Clin Infect Dis 35 1 (2002) 102-104
27. Galil K., Fair E., Mountcastle N., Britz P., and Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis 186 1 (2002) 102-105
28. Vazquez M., LaRussa P.S., Gershon A.A., Niccolai L.M., Muehlenbein C.E., Steinberg S.P., et al. Effectiveness over time of varicella vaccine. JAMA 291 7 (2004) 851-855
29. Lee B.R., Feaver S.L., Miller C.A., Hedberg C.W., and Ehresmann K.R. An elementary school outbreak of varicella attributed to vaccine failure: policy implications. J Infect Dis 190 3 (2004) 477-483
30. Marin M., Nguyen H.Q., Keen J., Jumaan A.O., Mellen P.M., Hayes E.B., et al. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003. Pediatrics 115 4 (2005) 900-905
31. Haddad M.B., Hill M.B., Pavia A.T., Green C.E., Jumaan A.O., De A.K., et al. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics 115 6 (2005) 1488-1493
32. Verstraeten T., Jumaan A.O., Mullooly J.P., Seward J.F., Izurieta H.S., DeStefano F., et al. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics 112 2 (2003) e98-103
33. Halloran M.E., Haber M., Longini Jr. I.M., and Struchiner C.J. Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol 133 4 (1991) 323-331
34. Heininger U., Baer G., Bonhoeffer J., and Schaad U.B. Reliability of varicella history in children and adolescents. Swiss Med Wkly 135 17-18 (2005) 252-255
35. Kavaliotis J., Petridou S., and Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 7 4 (2003) 274-277